Evidence map›Paper›PMID 30721404›Full record

ArticleWorld journal of pediatrics : WJP2019

Genetics of congenital and infantile nephrotic syndrome.

Sara Nawfal Sharief, Nada Abdullatif Hefni, Walaa Ali Alzahrani, Iman Ibrahim Nazer, Marwa Abdullah Bayazeed, Khalid A Alhasan, Osama Y Safdar, Sherif M El-Desoky, Jameela Abdulaziz Kari

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of pediatrics : WJP, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Congenital Nephrotic Syndrome in Oman:Sultan Qaboos University medical journal · 2026
    Article
  3. Article
  4. WT1-related disorders: more than Denys-Drash syndrome.Pediatric nephrology (Berlin, Germany) · 2024
    Review
  5. Article
  6. Article
  7. Genetic Variations and Clinical Features ofFrontiers in medicine · 2021
    Article
  8. Article
  9. Article
  10. Diagnostic and Management Challenges in Congenital Nephrotic Syndrome.Pediatric health, medicine and therapeutics · 2019
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sara Nawfal ShariefKing Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
Nada Abdullatif HefniKing Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
Walaa Ali AlzahraniKing Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
Iman Ibrahim NazerKing Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
Marwa Abdullah BayazeedKing Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
Khalid A AlhasanCollege of Medicine, Pediatric Department, King Saud University, Riyadh, Kingdom of Saudi Arabia.
Osama Y SafdarKing Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
Sherif M El-DesokyKing Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
Jameela Abdulaziz KariKing Abdulaziz University, Jeddah, Kingdom of Saudi Arabia. jkari@doctors.org.uk.
King Abdulaziz University · SAKing Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCongenital and infantile nephrotic syndrome (CNS and INS) are rare inherited defects in glomerular filtration involving a variety of gene mutations. This study aimed to analyze all genetic mutations associated with congenital and infantile nephrotic syndrome treated at our institution. We also discussed our different approach secondary to culture and resources.

methodsA retrospective single-center study of all children diagnosed as NS before the age of 1 year over a duration of over one decade.

resultsTwenty-nine children (12 boys) were included in the study. Their median age (range) was 2.4 (0.1-12) months (20 CNS and 9 INS). Consanguinity was present in 90% of children. The genetic analysis' results were only available for 20 children. An underlying causative homozygous mutation was detected in 18 children (90%): NPHS1 (9), NPHS2(2), LAMB2(3), PLCE1(1), WT1(1), and ITSN1 novel mutation (2). One child had heterozygous mutation of NPHS2 and another child had heterozygous mutation of NPHS1 which could not explain the disease. All CNS cases were all managed with intermittent intravenous albumin infusion, ACEi, diuretics, and indomethacin. None of the children were managed by nephrectomy followed by peritoneal dialysis (PD) because of limited resources. Only one child achieved partial remission, while 15 children died at a median (range) age of 5.8 (1.25-29) months. The remaining 14 children were followed up for an average of 36 (3.9-120) months. Three children progressed to end-stage kidney disease and PD was performed in only two children.

conclusionsNPHS1 is the main underlying cause of CNS and INS in our study population. CNS and INS were associated with high morbidity and mortality.

Indexed as

Academic Medical CentersAge DistributionChinaCohort StudiesCombined Modality TherapyDisease ProgressionFemaleGenetic Predisposition to DiseaseGenetic TestingHumansInfantInfant, NewbornIntracellular Signaling Peptides and ProteinsKidney Failure, ChronicMaleMembrane ProteinsIntracellular Signaling Peptides and ProteinsMembrane ProteinsCongenital nephroticGeneticsInfantile nephroticOutcome

Identifiers

PMID30721404
OpenAlexW2913300735

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.